Potential Metabolic Biomarkers for Early Detection of Oral Lichen Planus, a Precancerous Lesion

Xiao-Shuang Wang,Zhi Sun,Li-Wei Liu,Qiu-Zheng Du,Zhang-Suo Liu,Yan-Jie Yang,Peng Xue,Hong-Yu Zhao
DOI: https://doi.org/10.3389/fphar.2020.603899
IF: 5.6
2020-11-06
Frontiers in Pharmacology
Abstract:<span><strong>Background:</strong> Oral lichen planus (OLP) is a T-cell-mediated chronic inflammatory disorder and precancerous oral lesion with high incidence. The current diagnostic method of OLP is very limited and metabolomics may provide a new approach for quantitative evaluation.<strong>Methods:</strong> The Ultra-Performance Liquid Chromatography-Quadrupole/Orbitrap High Resolution Mass Spectrometry (UHPLC-Q-Orbitrap HRMS) was applied to analyze the change of metabolites in serum of patients with OLP. A total of 115 OLP patients and 124 healthy controls were assigned to either a training set (<em>n</em> = 160) or a test set (<em>n</em> = 79). The potential biomarkers and the change of serum metabolites were profiled and evaluated by multivariate analysis.<strong>Results:</strong> Totally, 23 differential metabolites were identified in the training set between OLP group and healthy group. Three prominent metabolites in receiver operating characteristic (ROC) were selected as a panel to distinguish OLP or healthy individuals in the test set, and the diagnostic accuracy was 86.1%.<strong>Conclusions:</strong> This study established a new method for the early detection of OLP by analyzing serum metabolomics using UHPLC-Q-Orbitrap HRMS, which will help in understanding the pathological processes of OLP and identifying precancerous lesions in oral cavity.</span>
pharmacology & pharmacy
What problem does this paper attempt to address?